Aisling Capital Partners III LLC

10% owner at Loxo Oncology, Inc.

Sold, on record
$20.1M
Dollars the filings state
Form 4 sales
1
Latest Dec 19, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Loxo Oncology, Inc.Plan not stated
    Dec 19, 2017 2017

    Sold 250,000 shares at $80.50 ($20.1M)

    Aisling Capital Partners III LLC, 10% owner

    Sold 6.8% of holdings ($297M position)3.4M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Aisling Capital Partners III LLC
Source
Dec 19, 2017Dec 20, 2017Loxo Oncology, Inc.10% ownerForm 4 sale250,000$20.1M6.8%Plan not statedSEC